HERLINA DIMIATI, SOFIA SOFIA, BASRI A. GANI
Acute rheumatic fever (ARF) is a sequela of streptococcal infection-typically following 2 to 3 weeks after group A streptococcal pharyngitis-that occurs most commonly in children and has rheumatologic, cardiac, and neurologic manifestations. Rheumatic heart disease (RHD) refers to the long-term cardiac damage caused by either a single severe episode or multiple recurrent episodes of ARF. Secondary prophylaxis with regular intramuscular injections of benzathine penicillin G (BPG) is a key component to prevent ARF and RHD recurrent. This study aimed to evaluate the secondary prophylaxis effectiveness based on the profile of clinical manifestations and blood laboratory findings. The data were collected by interviews, complete blood counts, the anti-streptolysin titer O (ASTO) analysis, the C-reactive protein Assay, electrocardiography, and echocardiography. Data were analyzed using SPSS 18, and the results were presented as the percentage frequency. The samples were 63 patients with ARF and RHD who get secondary prophylaxis, consisting of 32 males (50.8%) and 31 females (49.9%). The echocardiography examination showed that valve regurgitation was more common than valve stenosis, indicating longer P-R interval in 49 subjects (77.7%). Sixty subjects (92.2%) received secondary prophylaxis with BPG injection, and three subjects (4.8%) got Erythromycin oral. The main factor of secondary prophylaxis adherence is pain and injection disliking. © 2020 EManuscript Technologies. All rights reserved.
FACULTY OF MEDICINE, SYIAH KUALA UNIVERSITY, ZAINOEL ABIDIN HOSPITAL, BANDA ACEH, Indonesia; DEPARTMENT OF DENTISTRY, SYIAH KUALA UNIVERSITY, Syrian Arab Republic
Research at a Glance
Register to unlockTopics & SDG Alignment
Register to unlockCollaboration
Register to unlockAuthor Profile (Selected)
Register to unlockReferences Overview
Register to unlockJournal & Source
Register to unlockMetadata & Integrity
Register to unlock